Runway Growth Finance Corp. (RWAY) Q4 2025 Earnings Call Transcript
Access earnings results, analyst expectations, report, slides, earnings call, and transcript.
Overview
The earnings call reveals several negative financial trends: a decline in total investment income, net investment income, and portfolio value. While the acquisition of SWK Holdings and strategic plans are positive, the immediate financial performance is weak. The Q&A highlights cautious sentiment regarding leverage and challenges in building the Cadma JV portfolio. Although there are some positive developments, such as improved investment outcomes and strong liquidity, the overall sentiment is dampened by declining income and NAV, resulting in a negative outlook.
Key Financial Performance
Total Investment Income (Q4 2025) $30 million, a decrease compared to $36.7 million in Q3 2025. The decline was attributed to lower prepayment income in the quarter.
Net Investment Income (Q4 2025) $11.6 million, a decrease compared to $15.7 million in Q3 2025. The decline was due to lower prepayment fee income and other factors.
Fair Value of Total Investment Portfolio (Q4 2025) $927.4 million, a decrease of 2% from $946 million in Q3 2025. The decline reflects portfolio optimization actions and repayments.
Net Assets (Q4 2025) $484.9 million, a decrease from $489.5 million in Q3 2025. The decrease was due to portfolio adjustments and other financial activities.
Net Asset Value (NAV) per Share (Q4 2025) $13.42, a decrease of 1% compared to $13.55 in Q3 2025. The decline was attributed to portfolio adjustments and financial activities.
Debt Portfolio Yield (Q4 2025) 14.2%, a decrease from 16.8% in Q3 2025 and 14.7% in Q4 2024. The decline was due to lower prepayment income.
Operating Expenses (Q4 2025) $18.4 million, a decrease from $21 million in Q3 2025. The reduction reflects cost management efforts.
Net Realized Loss on Investments (Q4 2025) $377,000, compared to a net realized loss of $1.3 million in Q3 2025. The improvement reflects better investment outcomes.
Leverage Ratio (Q4 2025) 0.9, compared to 0.92 in Q3 2025. The slight decrease reflects adjustments in the financial structure.
Available Liquidity (Q4 2025) $395.2 million, including unrestricted cash and cash equivalents, with borrowing capacity of $377 million. This reflects strong liquidity management.
You have reached the limit. Sign up to access full content
Get started
Operating Highlights
New Investments: Runway completed 7 investments in new and existing portfolio companies across technology, healthcare, and select consumer sectors, totaling $42.9 million in funded loans.
Sector Focus: Investments included a $20 million investment in a mobility company, $10 million in a consumer products SPV, and $2 million in Shield Therapeutics, a pharmaceutical company.
Market Expansion: Runway is expanding its portfolio diversification and exposure to healthcare and life sciences through the acquisition of SWK Holdings, expected to close in April 2026.
Pipeline Growth: The company reported a stronger pipeline for 2026 compared to the previous year, with enhanced origination channels through BC Partners and SWK.
Portfolio Optimization: Runway is reducing average position sizes and enhancing risk profiles through diversification and smaller position sizes.
Financial Performance: Total investment income for Q4 2025 was $30 million, with net investment income of $11.6 million. The portfolio's fair value decreased by 2% to $927.4 million.
Strategic Acquisition: The acquisition of SWK Holdings aims to stabilize the asset base, expand healthcare exposure, and enhance earnings power.
AI Integration: Runway is focusing on software companies leveraging AI to optimize operations and improve market penetration.
You have reached the limit. Sign up to access full content
Get started
Risk or Challenges
Market Conditions: Uncertainties surrounding interest rates and changing economic conditions could adversely impact the company's performance.
Geopolitical Conflicts: Geopolitical conflicts have contributed to market volatility, posing risks to the company's operations and investment strategies.
Portfolio Risk Rating: The weighted average portfolio risk rating increased to 2.45 in Q4 2025, indicating a slight deterioration in credit quality.
Nonaccrual Loan: One loan, Domingo Healthcare, is on nonaccrual status with a fair market value of 50% of cost, representing a potential loss.
Prepayment Fee Income: Decline in prepayment fee income has negatively impacted net investment income.
SWK Transaction Timing: The modest delay in the SWK transaction closing will contribute to softness in Q1 2026 earnings.
Debt Portfolio Yield: The debt portfolio's dollar-weighted average annualized yield decreased from 16.8% to 14.2%, reflecting lower prepayment income.
Leverage Ratio: The leverage ratio remains high at 0.9, which could pose risks in a volatile market environment.
Unfunded Commitments: The company has $145.5 million in unfunded commitments, which could strain liquidity if drawn upon.
You have reached the limit. Sign up to access full content
Get started
Guidance & Outlook
Acquisition of SWK Holdings: The transaction with SWK Holdings is expected to close in early April 2026. This acquisition will diversify the portfolio, particularly in health care and life sciences, enhancing capabilities and driving optionality moving forward.
Pipeline and Origination Activity: The pipeline for the first quarter of 2026 is stronger compared to the same period last year, providing measured optimism for the remainder of 2026. Enhanced origination channels through BC Partners and SWK are expected to contribute to portfolio growth.
Sector Focus and Investment Strategy: Runway Growth Finance will continue to focus on technology, health care, and select consumer sectors. The company aims to broaden exposure across sectors while maintaining a disciplined investment framework to generate consistent, risk-adjusted returns.
Software Portfolio Outlook: The software portfolio is expected to leverage AI to optimize operations and accelerate market penetration. The portfolio is characterized by mission-critical functions, strong moats, and customer diversification, which derisks revenue growth projections.
Dividend Sustainability: The dividend is set at a sustainable level, and the Board will continue to evaluate future distributions to ensure consistency for shareholders.
Capital Allocation and Financial Profile: Following the SWK transaction, the average position size is expected to reduce to $23.5 million or 2.2% of the portfolio, compared to $30.3 million or 3.1% before the BC Partners transaction. This will enhance the portfolio's earnings power and reduce its risk profile.
You have reached the limit. Sign up to access full content
Get started
Shareholder Return Plan
Base Dividend: $0.33 per share in the fourth quarter of 2025.
Spillover Income: Approximately $0.65 per share at the end of the year.
First Quarter 2026 Dividend: Declared a regular distribution of $0.33 per share.
Stock Repurchase Program: Not utilized during the quarter due to the pending acquisition of SWK Holdings. Existing program will expire before the blackout window opens. Stock repurchases are viewed as an important tool for delivering shareholder value.
You have reached the limit. Sign up to access full content
Get started
Key Q&A
Q:Can you discuss the current pipeline in terms of new versus add-on opportunities and any industry trends?
A:The pipeline is stronger than last year, with significant contributions from BC Partners and SWK. BC Partners has been instrumental in deal flow, with plans for at least one deal per quarter. SWK offers opportunities to upsize loans. The competitive environment in software and consumer sectors is yielding good returns, but the company remains conservative in underwriting.
Q:What is the pro forma leverage number after the first quarter actions, and how is the appropriate level of leverage determined?
A:Post-SWK, leverage will be just under 1.2. The company aims to maintain leverage between 1.2 and 1.3, considering economic conditions and capital market volatility. Temporary increases above 1.35 may occur to protect core earnings during portfolio reconstruction.
Q:Are there any updates on the Cadma JV?
A:The Cadma JV has a couple of deals currently, but building the portfolio has been challenging. There is a renewed effort to enhance the portfolio, with the first distribution expected in Q2.
Q:Can you provide an update on the SWK Holdings portfolio and the expected loans coming over on April 6?
A:The SWK portfolio will include 13 loans with a fair value of around $235 million, along with an equity portfolio comprising stock positions, warrants, and royalties. The aggregate yield is about 14%, with the debt-only portfolio yielding around 16%.
Q:What is the status of the software portfolio, particularly the loan marked at a discount to par?
A:Circadence, a loan marked at a discount, has closed an equity round and signed a substantial Defense Department contract, indicating improved performance.
Q:How should the accretion level from the SWK transaction be viewed given stock price movements?
A:The equity component of $75.5 million is fixed, but the number of shares will vary based on NAV. Stock price declines increase the discount at which the portfolio is purchased, offsetting dilution effects.
Q:Why were no shares repurchased this quarter, and will repurchases resume post-acquisition?
A:Shares were not repurchased due to legal restrictions during the acquisition process. Repurchases may resume after the blackout period, likely in the second week of May, subject to Board approval.
Q:What is the remaining authorization for share repurchases?
A:The authorization exists but cannot be used currently. The Board will revisit the authorization in April or May.
Q:Why were proxy mail-outs for the merger delayed?
A:The delay was due to the SEC's extended review process, which took 72-77 days due to the complexity of the transaction and backlog. Once comments were received, the company responded promptly.
Q:Review of Unclear Management Responses
A:Management avoided directly addressing the question about the software portfolio's valuation, particularly regarding the media's expectation of marking it at zero. The response lacked clarity and specific details about the portfolio's future outlook.
You have reached the limit. Sign up to access full content
Get started
Earnings Word Cloud
The most frequently occurring keywords in this quarter's earning call
AI cost
AI disruption
AI tool
Blue Shift
Bombora opportunity
Completion investment
Holdings update
LTVs portfolio
Partners SWK
Relations statement
SWK Holdings
Shield Therapeutics
acquisition SWK
capability health
care consumer
close
confidence
consumer sector
cycle
diversification
health care
model
opportunity portfolio
outlook
portfolio activity
process
profile
progress
remainder
software company
software portfolio
technology health
transaction SWK
RWAY Transcript
Runway Growth Finance Corp. (RWAY) Q1 2026 Earnings Call Transcript
Unknown5-8
The earnings call reveals several concerns: increased operational costs, credit downgrades, and a higher leverage ratio, all of which point to financial strain. Despite a new share repurchase program and the SWK acquisition's potential accretive impact, the negative outlook on earnings due to nonaccrual loans and reduced investment income overshadows positives. The NAV decline and portfolio depreciation further suggest a challenging environment. The Q&A does not alleviate these concerns, indicating a likely negative stock price movement in the next two weeks.
Runway Growth Finance Corp. (RWAY) Q4 2025 Earnings Call Transcript
Unknown3-12
The earnings call reveals several negative financial trends: a decline in total investment income, net investment income, and portfolio value. While the acquisition of SWK Holdings and strategic plans are positive, the immediate financial performance is weak. The Q&A highlights cautious sentiment regarding leverage and challenges in building the Cadma JV portfolio. Although there are some positive developments, such as improved investment outcomes and strong liquidity, the overall sentiment is dampened by declining income and NAV, resulting in a negative outlook.
Runway Growth Finance Corp. (RWAY) Q3 2025 Earnings Call Transcript
Positive11-6
The earnings call summary indicates a positive sentiment overall, with strong financial performance, optimistic product development updates, and a shareholder return plan involving a stock repurchase program. Despite some muted market outlooks and competitive pressures, the Q&A section reflects a positive sentiment from analysts, especially regarding the SWK merger's accretive potential. The strategic plan and capital management efforts further support a positive outlook for the stock price in the short term.
Runway Growth Finance Corp. (RWAY) Q2 2025 Earnings Call Transcript
Unknown8-8
The earnings call shows mixed signals: strong liquidity and shareholder returns are positive, but there's a decrease in NAV per share and asset coverage. The Q&A reveals cautious management, with concerns over increased interest expenses and unclear guidance on JV benefits. Despite some positive developments like new products and strategic partnerships, the muted deal activity and management's cautious outlook suggest limited short-term stock price movement. Overall, these factors balance out, resulting in a neutral sentiment.
RWAY Slides
Runway Growth Q1 2026 slides: earnings miss amid SWK integration2026-05-07
Runway Growth Q4 2025 slides highlight expansion amid revenue miss2026-03-12
Runway Growth Finance Q3 2025 slides: Strategic acquisitions to boost portfolio amid yield compression2025-11-06
Runway Growth Finance Q2 2025 slides: portfolio stability and NAV growth amid market challenges2025-08-07
RWAY Report
Frequently Asked Questions
Where does this earnings call transcript come from?
All transcripts are sourced directly from the official live webcast or the company’s official investor relations website. We use the exact words spoken during the call with no paraphrasing of the core discussion.
How soon is the transcript available after the earnings call ends?
Full verbatim transcripts are typically published within 4–12 hours after the call ends. Same-day availability is guaranteed for all S&P 500 and most mid-cap companies.
Is the transcript edited or altered in any way?
No material content is ever changed or summarized in the “Full Transcript” section. We only correct obvious spoken typos (e.g., “um”, “ah”, repeated 10 times”, or clear misspoken ticker symbols) and add speaker names/titles for readability. Every substantive sentence remains 100% as spoken.
Why do some answers appear as “Unclear” or “Inaudible”?
When audio quality is poor or multiple speakers talk over each other, we mark the section instead of guessing. This ensures complete accuracy rather than introducing potential errors.
Who creates the AI Summary and Key Q&A highlights shown above the transcript?
They are generated by a specialized financial-language model trained exclusively on 15+ years of earnings transcripts. The model extracts financial figures, guidance, and tone with 97%+ accuracy and is regularly validated against human analysts. The full raw transcript always remains available for verification.
